| Abstract Submission Deadline | June 18(Fri), 2021 |
|---|---|
| Notification of Acceptance | July 28(Wed), 2021 |
All interested individuals can submit scientific abstract for KCR 2021 and note that all abstracts must be submitted via online submission system. Faxed or emailed abstract will not be accepted.
Abstract submission does not mean you are registered for the congress, so please make sure that you register through the website during the registration period.
Please read the guidelines below carefully before submitting an abstract.
The corresponding author must complete a disclosure form for potential conflict of interest. A conflict of interest may exist when an author (or author's institution or employer) has financial or personal relationships or affiliations that could influence (or bias) the author's decisions, work, or abstract. The ICMJE Uniform Disclosure Form for Potential Conflict of Interest (www.icmje.org/conflicts-of-interest/) will be used. Your submission will not be considered final until disclosure information is complete.
The ICMJE recommendations are a set of guidelines produced by the International Committee of Medical Journal Editors for standardising the ethics, preparation and formatting of manuscripts submitted to biomedical journals for publication. Compliance with the ICMJE recommendations is required by most leading biomedical journals.
| Language | English Only |
|---|---|
| Presentation Type | Original Article(Oral or Poster) , Case Report(Poster Only) |
| Title | Each word should be started with a capital letter. |
| Format |
Original Article – Oral or Poster
Background/Objective – Methods – Results - Conclusion
Case Report – Poster only
Case Description - Conclusion
|
| Length of Body | No longer than 300 words |
| Name | Please put your name in order of first name, middle name and the last name. |
| Contents | Only one figure or table is allowed. |
| Modification | Available until the deadline of the abstract submission at My Page. |
| 1 | Cytokines and mediators | 12 | Spondyloarthropathies and psoriatic arthritis |
|---|---|---|---|
| 2 | Osteoarthritis and biology of bone and joint | 13 | Behcet's disease |
| 3 | RA-pathogenesis and animal model | 14 | Vasculitis |
| 4 | RA-clinical aspects | 15 | Osteoporosis and metabolic bone diseases |
| 5 | RA-treatment | 16 | Fibromyalgia and soft tissue disorders |
| 6 | SLE-pathogenesis and animal model | 17 | Metabolic and crystal arthropathies |
| 7 | SLE-clinical aspects, APS | 18 | Pediatric rheumatology |
| 8 | SLE-treatment | 19 | Orthopedics & Rehabilitation |
| 9 | Systemic sclerosis and Raynaud's phenomenon | 20 | Epidemiology & Public health: COVID-19 & Rheumatic diseases |
| 10 | Idiopathic inflammatory myositis and muscle biology | 21 | Miscellaneous rheumatic and inflammatory diseases |
| 11 | Sjogren's syndrome |
All submitted abstracts will be reviewed by the Academic Affairs committee according to the review procedures
Notification of acceptance will be informed by e-mail to the abstract presenter and the corresponding author.
Abstract presenter should inform KCR 2021 Secretariat regarding their attendance confirmation.
The preferred session for your presentation can be changed after evaluation by the Academic Affairs committee and the presentation type (oral or poster) will be notified to the presenting author no later than July 28 (Wed), 2021. Case reports will be presented by poster only.
If you would like to withdraw an abstract, please fill out the “Withdrawal Request Form” and send an e-mail to the KCR 2021 Secretariat as soon as possible.
If the presenter of the accepted abstract does not register by the deadline for Pre-Registration, the abstract will be automatically withdrawn from the final program.
